Legacy Pharmaceutical Packaging recalls Legacy — Losartan Potassium USP
- Recall date
- March 15, 2019
- Source
- U.S. Food & Drug Administration (FDA) — recall announcement
- Brand / firm
- Legacy Pharmaceutical Packaging, Legacy
Why it was recalled
Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) — Unapproved Ingredient
What was recalled
Losartan Potassium USP
Read the official recall notice →
Get recall alerts
Free email alert whenever Legacy Pharmaceutical Packaging has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Legacy Pharmaceutical Packaging, Legacy